DYADIC INTERNATIONAL INC Prepaid Insurance
DYADIC INTERNATIONAL INC (DYAI) had Prepaid Insurance of $165.39 thousand as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidInsurance · last filed 2026-03-25
- 2025-12-31: Prepaid Insurance $165.39K.
- 2024-12-31: Prepaid Insurance $182.27K.
- 2023-12-31: Prepaid Insurance $209.89K.
- 2023-09-30: Prepaid Insurance $311.39K.
| Period end | Prepaid Insurance |
|---|---|
| 2025-12-31 | $165.39K 10-K · filed 2026-03-25 |
| 2024-12-31 | $182.27K 10-K · filed 2026-03-25 |
| 2023-12-31 | $209.89K 10-K · filed 2025-03-26 |
| 2023-09-30 | $311.39K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $41.96K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $123.11K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $265.43K 10-K · filed 2024-03-28 |
| 2022-09-30 | $382.05K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $29.52K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $148.73M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $326.71K 10-K · filed 2023-03-29 |
| 2021-09-30 | $504.69K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $22.32K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $94.84K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $204.99K 10-K · filed 2022-03-29 |
| 2020-09-30 | $103.81K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $166.33K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $88.61K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $173.89K 10-K · filed 2021-03-30 |
| 2019-09-30 | $255.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $8.21K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $46.98K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $91.72K 10-K · filed 2020-03-30 |
| 2017-12-31 | $89.76K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |